S&P 500   4,272.46 (-0.04%)
DOW   33,890.48 (-0.26%)
QQQ   329.80 (+0.40%)
AAPL   173.93 (-0.36%)
MSFT   290.52 (-0.27%)
META   174.75 (-0.06%)
GOOGL   120.23 (+0.57%)
AMZN   141.87 (-0.16%)
TSLA   913.40 (+0.15%)
NVDA   187.23 (+2.12%)
NIO   19.88 (-1.00%)
BABA   90.43 (+0.74%)
AMD   100.27 (+2.04%)
MU   62.88 (+2.04%)
T   18.44 (+0.11%)
CGC   3.79 (-6.65%)
F   16.03 (+0.00%)
GE   79.44 (-0.60%)
DIS   122.46 (-0.28%)
AMC   20.19 (-5.48%)
PYPL   98.73 (-0.69%)
PFE   48.75 (-1.06%)
NFLX   244.80 (+1.51%)
S&P 500   4,272.46 (-0.04%)
DOW   33,890.48 (-0.26%)
QQQ   329.80 (+0.40%)
AAPL   173.93 (-0.36%)
MSFT   290.52 (-0.27%)
META   174.75 (-0.06%)
GOOGL   120.23 (+0.57%)
AMZN   141.87 (-0.16%)
TSLA   913.40 (+0.15%)
NVDA   187.23 (+2.12%)
NIO   19.88 (-1.00%)
BABA   90.43 (+0.74%)
AMD   100.27 (+2.04%)
MU   62.88 (+2.04%)
T   18.44 (+0.11%)
CGC   3.79 (-6.65%)
F   16.03 (+0.00%)
GE   79.44 (-0.60%)
DIS   122.46 (-0.28%)
AMC   20.19 (-5.48%)
PYPL   98.73 (-0.69%)
PFE   48.75 (-1.06%)
NFLX   244.80 (+1.51%)
S&P 500   4,272.46 (-0.04%)
DOW   33,890.48 (-0.26%)
QQQ   329.80 (+0.40%)
AAPL   173.93 (-0.36%)
MSFT   290.52 (-0.27%)
META   174.75 (-0.06%)
GOOGL   120.23 (+0.57%)
AMZN   141.87 (-0.16%)
TSLA   913.40 (+0.15%)
NVDA   187.23 (+2.12%)
NIO   19.88 (-1.00%)
BABA   90.43 (+0.74%)
AMD   100.27 (+2.04%)
MU   62.88 (+2.04%)
T   18.44 (+0.11%)
CGC   3.79 (-6.65%)
F   16.03 (+0.00%)
GE   79.44 (-0.60%)
DIS   122.46 (-0.28%)
AMC   20.19 (-5.48%)
PYPL   98.73 (-0.69%)
PFE   48.75 (-1.06%)
NFLX   244.80 (+1.51%)
S&P 500   4,272.46 (-0.04%)
DOW   33,890.48 (-0.26%)
QQQ   329.80 (+0.40%)
AAPL   173.93 (-0.36%)
MSFT   290.52 (-0.27%)
META   174.75 (-0.06%)
GOOGL   120.23 (+0.57%)
AMZN   141.87 (-0.16%)
TSLA   913.40 (+0.15%)
NVDA   187.23 (+2.12%)
NIO   19.88 (-1.00%)
BABA   90.43 (+0.74%)
AMD   100.27 (+2.04%)
MU   62.88 (+2.04%)
T   18.44 (+0.11%)
CGC   3.79 (-6.65%)
F   16.03 (+0.00%)
GE   79.44 (-0.60%)
DIS   122.46 (-0.28%)
AMC   20.19 (-5.48%)
PYPL   98.73 (-0.69%)
PFE   48.75 (-1.06%)
NFLX   244.80 (+1.51%)
OTCMKTS:ECTE

Echo Therapeutics - ECTE Stock Forecast, Price & News

$0.0002
0.00 (0.00%)
(As of 09/7/2021)
Add
Compare
Today's Range
$0.00
$0.00
50-Day Range
N/A
52-Week Range
$0.00
$0.28
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ECTE stock logo

About Echo Therapeutics (OTCMKTS:ECTE) Stock

Echo Therapeutics, Inc. is a medical device company, which engages in the development of non-invasive, and wireless continuous glucose monitoring system for use in the diabetes outpatient market. It offers needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose and delivery of topical pharmaceuticals. The company was founded in 1989 and is headquartered in Iselin, NJ.

Receive ECTE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Echo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ECTE Stock News Headlines

Echo Therapeutics Inc.
News for Echo Therapeutics Inc
Echo Therapeutics (ECTE) Stock
Echo Therapeutics Inc
3 Stocks Pushing The Drugs Industry Lower
See More Headlines
Receive ECTE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Echo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ECTE Company Calendar

Last Earnings
8/12/2016
Today
8/18/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:ECTE
Previous Symbol
NASDAQ:ECTE
Employees
17
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A














ECTE Stock - Frequently Asked Questions

How have ECTE shares performed in 2022?

Echo Therapeutics' stock was trading at $0.0002 on January 1st, 2022. Since then, ECTE stock has increased by 0.0% and is now trading at $0.0002.
View the best growth stocks for 2022 here
.

How were Echo Therapeutics' earnings last quarter?

Echo Therapeutics, Inc. (OTCMKTS:ECTE) announced its earnings results on Friday, August, 12th. The medical device company reported ($0.82) earnings per share for the quarter. During the same period last year, the firm posted ($0.97) EPS.

What other stocks do shareholders of Echo Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Echo Therapeutics investors own include Biocept (BIOC), DexCom (DXCM), Rexahn Pharmaceuticals (REXN), Acer Therapeutics (ACER), Athersys (ATHX), CytRx (CYTR), Glu Mobile (GLUU), InterCloud Systems (ICLD), NetApp (NTAP) and ReShape Lifesciences (RSLS).

What is Echo Therapeutics' stock symbol?

Echo Therapeutics trades on the OTCMKTS under the ticker symbol "ECTE."

How do I buy shares of Echo Therapeutics?

Shares of ECTE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Echo Therapeutics' stock price today?

One share of ECTE stock can currently be purchased for approximately $0.00.

How can I contact Echo Therapeutics?

Echo Therapeutics' mailing address is 99 WOOD AVENUE SOUTH SUITE 302, ISELIN NJ, 08830. The official website for the company is www.echotx.com. The medical device company can be reached via phone at (732) 201-4194, via email at colimpio@echotx.com, or via fax at 215-717-4109.

This page (OTCMKTS:ECTE) was last updated on 8/18/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.